0.7774
Vaxart Inc (VXRT) 最新ニュース
3 Stocks Under $5 With Strong Analyst Upside Potential - Investing.com
3 Stocks Under $5 With Strong Analyst Upside Potential - Investing.com
Vaxart (OTCMKTS:VXRT) Stock Price Passes Above Fifty Day Moving AverageWhat's Next? - MarketBeat
Vaxart (VXRT) Stock Price, News & Analysis $VXRT - MarketBeat
Vaxart (VXRT) Stock Forecast and Price Target 2026 $VXRT - MarketBeat
Will Vaxart Inc. benefit from geopolitical trendsEarnings Risk Summary & Community Shared Stock Ideas - mfd.ru
Vaxart to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference on February 25, 2026 - The Manila Times
Aug Patterns: Will Vaxart Inc outperform small cap indexes2025 Volatility Report & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Rate Hike: Whats the RSI of Vaxart Inc stockJuly 2025 Decliners & Low Risk Entry Point Tips - baoquankhu1.vn
Is Vaxart Inc. a play on infrastructure spending2025 Big Picture & Trade Opportunity Analysis - mfd.ru
Is Vaxart Inc.’s ROE strong enoughJuly 2025 Selloffs & Weekly High Return Opportunities - mfd.ru
Will Vaxart Inc. stock pay special dividendsEarnings Performance Report & Capital Efficiency Focused Strategies - mfd.ru
Will Vaxart Inc. stock continue dividend increases2025 Price Action Summary & Free High Return Stock Watch Alerts - mfd.ru
Vaxart soars on positive data from new norovirus vaccine trial - MSN
Vaxart (VXRT) Valuation After New npj Vaccines Data On Oral Norovirus Candidate In Breastfeeding Women - Yahoo Finance
Does Vaxart’s (VXRT) Early Norovirus Infant Data Hint At A Broader Oral Vaccine Platform Advantage? - simplywall.st
Vaxart, Inc. Leads Six-Month Stock Returns with 59.48% Gain - Markets Mojo
Vaxart (NASDAQ:VXRT) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Lobbying Update: $50,000 of VAXART INC. lobbying was just disclosed - Quiver Quantitative
The 3 Penny Stocks You Swore You’d Never Buy (But You’ll Check Anyway) - MarketBeat
Vaxart (VXRT) Advances Oral Vaccine with Promising Phase 1 Trial Results - GuruFocus
Vaxart Publishes Positive Phase 1 Trial Results for Oral Norovirus Vaccine in Breastfeeding Women, Highlighting Passive Immunity Transfer to Infants - Quiver Quantitative
Vaxart Publishes Positive Data for its Oral Bivalent Norovirus Candidate in Lactating Women and Their Infants - Yahoo Finance
Vaxart secures $105.9 million more for COVID-19 pill vaccine trial - MSN
Vaxart’s Oral Vaccine Bet Hits A Funding Wall - Finimize
Can Celldex Therapeutics Inc disrupt its industry2025 Geopolitical Influence & Reliable Price Action Trade Plans - baoquankhu1.vn
Is Vaxart Inc. stock supported by strong fundamentalsJuly 2025 Trade Ideas & AI Driven Price Predictions - Улправда
Will Vaxart Inc. stock outperform international peersMarket Trend Review & Technical Pattern Recognition Alerts - Улправда
Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - The Manila Times
Aug Sentiment: How geopolitical tensions affect Vaxart Inc. stockQuarterly Portfolio Summary & Fast Entry Momentum Trade Alerts - ulpravda.ru
Why Vaxart Inc. (NB11) stock attracts wealthy investorsEarnings Growth Patterns & Superior Capital Growth - ulpravda.ru
Vaxart Inc Stock Analysis and ForecastVolume Spike Alerts & Free Stock Index Interpretations - Early Times
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results - ADVFN
Moving Averages: What valuation ratios show for Vaxart Inc NB11 stock2025 AllTime Highs & Daily Oversold Stock Bounce Ideas - Bộ Nội Vụ
VAXART, INC. (VXRT) Reports Q2 Loss, Beats Revenue Estimates - MSN
Vaxart Q3 2025 Earnings Preview - MSN
Vaxart to relocate headquarters amid lease termination - MSN
Vaxart to Relocate Headquarters Amid Lease Termination - The Globe and Mail
Vaxart to terminate headquarters lease early, plans relocation in South San Francisco - Investing.com Nigeria
Vaxart (VXRT) terminates South San Francisco HQ lease and plans relocation - Stock Titan
Vaxart (NASDAQ:VXRT) Shares Cross Below 200-Day Moving AverageTime to Sell? - MarketBeat
Will Vaxart Inc. stock outperform tech sector in 2025July 2025 Action & Weekly Setup with ROI Potential - Улправда
Will Vaxart Inc. stock benefit from automationJuly 2025 Sentiment & Daily Stock Trend Watchlist - Улправда
Why Vaxart Inc. (NB11) stock fits value portfolios2025 Volatility Report & Growth Oriented Trade Recommendations - Улправда
Is Vaxart Inc. stock undervalued vs historical averagesWatch List & Community Consensus Picks - Улправда
大文字化:
|
ボリューム (24 時間):